fda warning bpc-157 compounding Fast-growing peptide business faces crucial week at the FDA panel votes to place

By Monday morning, worst has passed

Every batch of product is rigorously tested, produced in FDA-registered & cGMP certified facilities, and traceable down to the lot numberso you can verify purity, potency, and safety

Cagrilintide and the combination drug CagriSema are investigational treatments currently undergoing regulatory review

Man, I couldn't walk up his driveway

You technically already have thousands of peptides in your body

Status Not FDA approved 19 June 2026 Jurisdiction or evidence type Australia / TGA Event TGA and Australia's Chief Medical Officer include BPC-157 among unapproved peptide products of public-health concern